Cholinergic anti-inflammatory pathway and connective tissue diseases.
Animals
Cholinergic Agents
/ pharmacology
Connective Tissue Diseases
/ immunology
Humans
Implantable Neurostimulators
Inflammation Mediators
/ antagonists & inhibitors
Neuroimmunomodulation
/ drug effects
Receptors, Nicotinic
/ immunology
Signal Transduction
/ drug effects
alpha7 Nicotinic Acetylcholine Receptor
/ antagonists & inhibitors
Cholinergic anti-inflammatory pathway
Connective tissue diseases
Inflammation response
Therapeutic intervention
Journal
Inflammopharmacology
ISSN: 1568-5608
Titre abrégé: Inflammopharmacology
Pays: Switzerland
ID NLM: 9112626
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
11
09
2020
accepted:
24
04
2021
pubmed:
15
6
2021
medline:
1
1
2022
entrez:
14
6
2021
Statut:
ppublish
Résumé
Connective tissue diseases (CTDs) consist of an extensive range of heterogeneous medical conditions, which are caused by immune-mediated chronic inflammation and influences the various connective tissues of the body. They include rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, vasculitis, Sjögren's syndrome, Behcet's disease, and many other autoimmune CTDs. To date, several anti-inflammatory approaches have been developed to reduce the severity of inflammation or its subsequent organ manifestations. As a logical mechanism to harnesses the undesired inflammation, some studies investigated the role of the intrinsic cholinergic anti-inflammatory pathway (CAP) in the modulation of chronic inflammation. Many different experimental and clinical models have been developed to evaluate the therapeutic significance of the CAP in CTDs. On the other hand, an issue that is less emphasized in this regard is the presence of autonomic neuropathy in CTDs, which influences the efficiency of CAP in such clinical settings. This condition occurs during CTDs and is a well-known complication of patients suffering from them. The advantages and limitations of CAP in the control of inflammatory responses and its possible therapeutic benefits in the treatment of CTDs are the main subjects of the current study. Therefore, this narrative review article is provided based on the recent findings of the complicated role of CAP in CTDs which were retrieved by searching Science Direct, PubMed, Google Scholar, and Web of Science. It seems that delineating the complex influences of CAP would be of great interest in designing novel surgical or pharmacological therapeutic strategies for CTDs therapy.
Identifiants
pubmed: 34125373
doi: 10.1007/s10787-021-00812-z
pii: 10.1007/s10787-021-00812-z
doi:
Substances chimiques
Cholinergic Agents
0
Inflammation Mediators
0
Receptors, Nicotinic
0
alpha7 Nicotinic Acetylcholine Receptor
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
975-986Subventions
Organisme : Tabriz University of Medical Sciences
ID : 59256
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Addorisio ME, Imperato GH, de Vos AF et al (2019) Investigational treatment of rheumatoid arthritis with a vibrotactile device applied to the external ear. Bioelectron Med 5:4. https://doi.org/10.1186/s42234-019-0020-4
doi: 10.1186/s42234-019-0020-4
pubmed: 32232095
pmcid: 7098240
Alunno A, Carubbi F, Giacomelli R, Gerli R (2017) Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol 1:3. https://doi.org/10.1186/s41927-017-0001-8
doi: 10.1186/s41927-017-0001-8
pubmed: 30886947
pmcid: 6383595
Amaral TN, Peres FA, Lapa AT et al (2013) Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum 43:335–347. https://doi.org/10.1016/j.semarthrit.2013.05.002
doi: 10.1016/j.semarthrit.2013.05.002
pubmed: 23827688
Amor-Dorado JC, Barreira-Fernández MP, Vázquez-Rodríguez TR et al (2011) Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in ankylosing spondylitis. Otol Neurotol 32:278–283. https://doi.org/10.1097/MAO.0b013e3182016534
doi: 10.1097/MAO.0b013e3182016534
pubmed: 21150686
Benfante R, Di Lascio S, Cardani S, Fornasari D (2019) Acetylcholinesterase inhibitors targeting the cholinergic anti-inflammatory pathway: a new therapeutic perspective in aging-related disorders. Aging Clin Exp Res. https://doi.org/10.1007/s40520-019-01359-4
doi: 10.1007/s40520-019-01359-4
pubmed: 31583530
Bertsias GK, Boumpas DT (2010) Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations. Nat Rev Rheumatol 6:358–367. https://doi.org/10.1038/nrrheum.2010.62
doi: 10.1038/nrrheum.2010.62
pubmed: 20458332
Bhattacharyya S, Helfgott S (2014) Neurologic complications of systemic lupus erythematosus, sjögren syndrome, and rheumatoid arthritis. Semin Neurol 34:425–436. https://doi.org/10.1055/s-0034-1390391
doi: 10.1055/s-0034-1390391
pubmed: 25369438
Bonaz B, Sinniger V, Pellissier S (2017) The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract. Front Immunol. https://doi.org/10.3389/fimmu.2017.01452
doi: 10.3389/fimmu.2017.01452
pubmed: 29163522
pmcid: 5673632
Borovikova LV, Ivanova S, Zhang M et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458–462. https://doi.org/10.1038/35013070
doi: 10.1038/35013070
pubmed: 10839541
Bougea A, Anagnostou E, Spandideas N et al (2015) An update of neurological manifestations of vasculitides and connective tissue diseases: a literature review. Einstein (são Paulo) 13:627–635. https://doi.org/10.1590/S1679-45082015RW3308
doi: 10.1590/S1679-45082015RW3308
pmcid: 4878643
Brites L, Ribeiro J, Matos A, Santiago M (2020) Neurological findings in Behçet’s disease. JCR J Clin Rheumatol 26:e185–e186. https://doi.org/10.1097/RHU.0000000000001057
doi: 10.1097/RHU.0000000000001057
pubmed: 31107697
Bruchfeld A, Goldstein RS, Chavan S et al (2010) Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis. J Intern Med. https://doi.org/10.1111/j.1365-2796.2010.02226.x
doi: 10.1111/j.1365-2796.2010.02226.x
pubmed: 20337855
pmcid: 2937357
Burska A, Boissinot M, Ponchel F (2014) Cytokines as biomarkers in rheumatoid arthritis. Mediators Inflamm 2014:1–24. https://doi.org/10.1155/2014/545493
doi: 10.1155/2014/545493
Chavan SS, Tracey KJ (2017) Essential neuroscience in immunology. J Immunol 198:3389–3397
doi: 10.4049/jimmunol.1601613
Chavan SS, Pavlov VA, Tracey KJ (2017) Mechanisms and Therapeutic Relevance of Neuro-immune Communication. Immunity 46:927–942. https://doi.org/10.1016/j.immuni.2017.06.008
doi: 10.1016/j.immuni.2017.06.008
pubmed: 28636960
pmcid: 5578398
Chu C, Artis D, Chiu IM (2020) Neuro-immune Interactions in the Tissues. Immunity 52:464–474. https://doi.org/10.1016/j.immuni.2020.02.017
doi: 10.1016/j.immuni.2020.02.017
pubmed: 32187517
Ciancio G, Colina M, La Corte R et al (2010) Nicotine-patch therapy on mucocutaneous lesions of Behcet’s disease: a case series. Rheumatology 49:501–504. https://doi.org/10.1093/rheumatology/kep401
doi: 10.1093/rheumatology/kep401
pubmed: 20015973
Ciccia F, Guggino G, Giardina A et al (2014) The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren’s syndrome. Expert Rev Clin Immunol 10:533–541. https://doi.org/10.1586/1744666X.2014.884461
doi: 10.1586/1744666X.2014.884461
pubmed: 24490899
Das UN (2011) Can vagus nerve stimulation halt or ameliorate rheumatoid arthritis and lupus? Lipids Health Dis 10:19. https://doi.org/10.1186/1476-511X-10-19
doi: 10.1186/1476-511X-10-19
pubmed: 21261967
pmcid: 3037330
Doridot L, Jeljeli M, Chêne C, Batteux F (2019) Implication of oxidative stress in the pathogenesis of systemic sclerosis via inflammation, autoimmunity and fibrosis. Redox Biol 25:101122. https://doi.org/10.1016/j.redox.2019.101122
doi: 10.1016/j.redox.2019.101122
pubmed: 30737171
pmcid: 6859527
Dou Y, Luo J, Yu J et al (2019) Cholinergic system is involved in the therapeutic effect of madecassoside on collagen-induced arthritis in rats. Int Immunopharmacol 75:105813. https://doi.org/10.1016/j.intimp.2019.105813
doi: 10.1016/j.intimp.2019.105813
pubmed: 31404889
Eftekhari G, Hajiasgharzadeh K, Ahmadi-Soleimani SM et al (2014) Activation of central muscarinic receptor type 1 prevents development of endotoxin tolerance in rat liver. Eur J Pharmacol 740:436–441. https://doi.org/10.1016/j.ejphar.2014.06.050
doi: 10.1016/j.ejphar.2014.06.050
pubmed: 25008070
Fasano S, Isenberg DA (2019) Present and novel biologic drugs in primary Sjögren’s syndrome. Clin Exp Rheumatol 37(Suppl 1):167–174
pubmed: 31025931
Filippini P, Cesario A, Fini M et al (2012) The yin and yang of non-neuronal ?7-nicotinic receptors in inflammation and autoimmunity. Curr Drug Targets 13:644–655. https://doi.org/10.2174/138945012800399008
doi: 10.2174/138945012800399008
pubmed: 22300039
Forsgren S (2012) Presence of ChAT mRNA and a very marked α7nAChR immunoreaction in the synovial lining layer of the knee joint. Life Sci 91:1043–1047. https://doi.org/10.1016/j.lfs.2012.03.028
doi: 10.1016/j.lfs.2012.03.028
pubmed: 22483691
Gomes JP, Watad A, Shoenfeld Y (2018) Nicotine and autoimmunity: the lotus’ flower in tobacco. Pharmacol Res 128:101–109. https://doi.org/10.1016/j.phrs.2017.10.005
doi: 10.1016/j.phrs.2017.10.005
pubmed: 29051105
Gorson KC (2007) Vasculitic neuropathies. Neurologist 13:12–19. https://doi.org/10.1097/01.nrl.0000252942.14928.17
doi: 10.1097/01.nrl.0000252942.14928.17
pubmed: 17215723
Gowayed MA, Rothe K, Rossol M et al (2019) The role of α7nAChR in controlling the anti-inflammatory/anti-arthritic action of galantamine. Biochem Pharmacol 170:113665. https://doi.org/10.1016/j.bcp.2019.113665
doi: 10.1016/j.bcp.2019.113665
pubmed: 31606410
Hajiasgharzadeh K, Baradaran B (2017) Cholinergic anti-inflammatory pathway and the liver. Adv Pharm Bull 7:507–513. https://doi.org/10.15171/apb.2017.063
doi: 10.15171/apb.2017.063
pubmed: 29399541
pmcid: 5788206
Hajiasgharzadeh K, Tavangar SM, Javan M et al (2014) Does hepatic vagus nerve modulate the progression of biliary fibrosis in rats? Auton Neurosci Basic Clin 185:67–75. https://doi.org/10.1016/j.autneu.2014.07.005
doi: 10.1016/j.autneu.2014.07.005
Huston JM, Gallowitsch-Puerta M, Ochani M et al (2007) Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis*. Crit Care Med 35:2762–2768. https://doi.org/10.1097/01.CCM.0000288102.15975.BA
doi: 10.1097/01.CCM.0000288102.15975.BA
pubmed: 17901837
Imrich R, Alevizos I, Bebris L et al (2015) Predominant glandular cholinergic dysautonomia in patients with primary sjögren’s syndrome. Arthritis Rheumatol 67:1345–1352. https://doi.org/10.1002/art.39044
doi: 10.1002/art.39044
pubmed: 25622919
pmcid: 4414824
Jin PH, Shin SC (2019) Neuropathy of connective tissue diseases and other systemic diseases. Semin Neurol 39:651–668. https://doi.org/10.1055/s-0039-1688989
doi: 10.1055/s-0039-1688989
pubmed: 31639847
Jog NR, James JA (2017) Biomarkers in connective tissue diseases. J Allergy Clin Immunol 140:1473–1483. https://doi.org/10.1016/j.jaci.2017.10.003
doi: 10.1016/j.jaci.2017.10.003
pubmed: 29221579
pmcid: 5819750
Kalayciyan A, Orawa H, Fimmel S et al (2007) Nicotine and biochanin a, but not cigarette smoke, induce anti-inflammatory effects on keratinocytes and endothelial cells in patients with Behçet’s disease. J Invest Dermatol 127:81–89. https://doi.org/10.1038/sj.jid.5700492
doi: 10.1038/sj.jid.5700492
pubmed: 17008886
Kanashiro A, Bassi GS, de Queiróz Cunha F, Ulloa L (2018) From neuroimunomodulation to bioelectronic treatment of rheumatoid arthritis. Bioelectron Med 1:151–165. https://doi.org/10.2217/bem-2018-0001
doi: 10.2217/bem-2018-0001
Koopman FA, Stoof SP, Straub RH et al (2011) Restoring the balance of the autonomic nervous system as an innovative approach to the treatment of rheumatoid arthritis. Mol Med 17:937–948. https://doi.org/10.2119/molmed.2011.00065
doi: 10.2119/molmed.2011.00065
pubmed: 21607292
pmcid: 3188868
Koopman FA, Schuurman PR, Vervoordeldonk MJ, Tak PP (2014) Vagus nerve stimulation: a new bioelectronics approach to treat rheumatoid arthritis? Best Pract Res Clin Rheumatol 28:625–635. https://doi.org/10.1016/j.berh.2014.10.015
doi: 10.1016/j.berh.2014.10.015
pubmed: 25481554
Koopman FA, Chavan SS, Miljko S et al (2016) Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci 113:8284–8289. https://doi.org/10.1073/pnas.1605635113
doi: 10.1073/pnas.1605635113
pubmed: 27382171
pmcid: 4961187
Levine YA, Koopman FA, Faltys M et al (2014) Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis. PLoS ONE 9:e104530. https://doi.org/10.1371/journal.pone.0104530
doi: 10.1371/journal.pone.0104530
pubmed: 25110981
pmcid: 4128811
Li T, Zuo X, Zhou Y et al (2010) The vagus nerve and nicotinic receptors involve inhibition of HMGB1 release and early pro-inflammatory cytokines function in collagen-induced arthritis. J Clin Immunol 30:213–220. https://doi.org/10.1007/s10875-009-9346-0
doi: 10.1007/s10875-009-9346-0
pubmed: 19890701
Li S, Zhou B, Liu B et al (2016) Activation of the cholinergic anti-inflammatory system by nicotine attenuates arthritis via suppression of macrophage migration. Mol Med Rep 14:5057–5064. https://doi.org/10.3892/mmr.2016.5904
doi: 10.3892/mmr.2016.5904
pubmed: 27840928
pmcid: 5355730
Li Z, Hao H, Gao Y et al (2019) Expression and localization analyses of the cholinergic anti-inflammatory pathway and α7nAchR in different tissues of rats with rheumatoid arthritis. Acta Histochem 121:742–749. https://doi.org/10.1016/j.acthis.2019.07.001
doi: 10.1016/j.acthis.2019.07.001
pubmed: 31279484
Liao KP, Costenbader KH (2009) Getting them even earlier: Identifying individuals before clinical presentation with rheumatoid arthritis. Arthritis Rheum 61:1620–1622. https://doi.org/10.1002/art.24991
doi: 10.1002/art.24991
pubmed: 19950327
pmcid: 2838473
Lina C, Conghua W, Nan L, Ping Z (2011) Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis. J Clin Immunol 31:596–605. https://doi.org/10.1007/s10875-011-9542-6
doi: 10.1007/s10875-011-9542-6
pubmed: 21562776
Liote F, Osterland CK (1994) Autonomic neuropathy in systemic lupus erythematosus: cardiovascular autonomic function assessment. Ann Rheum Dis 53:671–674
doi: 10.1136/ard.53.10.671
Maanen MA, Papke RL, Koopman FA et al (2015) Two Novel nicotinic acetylcholine receptor ligands in vitro properties and their efficacy in collagen-induced arthritis in mice. PLoS ONE 10:e0116227. https://doi.org/10.1371/journal.pone.0116227
doi: 10.1371/journal.pone.0116227
pubmed: 25617631
pmcid: 4305287
Mani AR, Montagnese S, Jackson CD et al (2009) Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol 296:G330–G338. https://doi.org/10.1152/ajpgi.90488.2008
doi: 10.1152/ajpgi.90488.2008
pubmed: 19023029
McAllen RM, Cook AD, Khiew HW et al (2015) The interface between cholinergic pathways and the immune system and its relevance to arthritis. Arthritis Res Ther 17:87. https://doi.org/10.1186/s13075-015-0597-2
doi: 10.1186/s13075-015-0597-2
pubmed: 25889979
pmcid: 4378008
Nutma E, Willison H, Martino G, Amor S (2019) Neuroimmunology - the past, present and future. Clin Exp Immunol 197:278–293. https://doi.org/10.1111/cei.13279
doi: 10.1111/cei.13279
pubmed: 30768789
pmcid: 6693969
Ohtsuji M, Lin Q, Nishikawa K et al (2015) IL-6 signal blockade ameliorates the enhanced osteoclastogenesis and the associated joint destruction in a novel FcγRIIB-deficient rheumatoid arthritis mouse model. Mod Rheumatol 25:270–277. https://doi.org/10.3109/14397595.2014.950035
doi: 10.3109/14397595.2014.950035
pubmed: 25159156
Otón T, Carmona L (2019) The epidemiology of established rheumatoid arthritis. Best Pract Res Clin Rheumatol 33:101477. https://doi.org/10.1016/j.berh.2019.101477
doi: 10.1016/j.berh.2019.101477
pubmed: 31987685
Pavlakis PP, Alexopoulos H, Kosmidis ML et al (2011) Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J Neurol Neurosurg Psychiatry 82:798–802. https://doi.org/10.1136/jnnp.2010.222109
doi: 10.1136/jnnp.2010.222109
pubmed: 21172862
Pavlov VA (2019) Collateral benefits of studying the vagus nerve in bioelectronic medicine. Bioelectron Med 5:5. https://doi.org/10.1186/s42234-019-0021-3
doi: 10.1186/s42234-019-0021-3
pubmed: 32232096
pmcid: 7098239
Pavlov VA, Chavan SS, Tracey KJ (2018) Molecular and functional neuroscience in immunity. Annu Rev Immunol 36:783–812. https://doi.org/10.1146/annurev-immunol-042617-053158
doi: 10.1146/annurev-immunol-042617-053158
pubmed: 29677475
pmcid: 6057146
Peng C, Shi Q, Liu J et al (2019) Alpha7 nAChR expression is correlated with arthritis development and inhibited by sinomenine in adjuvant-induced arthritic rats. Evidence-Based Complement Altern Med 2019:1–11. https://doi.org/10.1155/2019/3759304
doi: 10.1155/2019/3759304
Pham GS, Wang LA, Mathis KW (2018) Pharmacological potentiation of the efferent vagus nerve attenuates blood pressure and renal injury in a murine model of systemic lupus erythematosus. Am J Physiol Integr Comp Physiol 315:R1261–R1271. https://doi.org/10.1152/ajpregu.00362.2017
doi: 10.1152/ajpregu.00362.2017
Pham GS, Gusson Shimoura C, Chaudhari S et al (2020) Chronic unilateral cervical vagotomy reduces renal inflammation, blood pressure, and renal injury in a mouse model of lupus. Am J Physiol Physiol. https://doi.org/10.1152/ajprenal.00201.2020
doi: 10.1152/ajprenal.00201.2020
Reardon C (2016) Neuro-immune interactions in the cholinergic anti-inflammatory reflex. Immunol Lett 178:92–96. https://doi.org/10.1016/j.imlet.2016.08.006
doi: 10.1016/j.imlet.2016.08.006
pubmed: 27542331
Riboldi P, Gerosa M, Luzzana C, Catelli L (2002) Cardiac involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 23:247–262. https://doi.org/10.1385/CRIAI:23:3:247
doi: 10.1385/CRIAI:23:3:247
pubmed: 12402411
Rosas-Ballina M, Olofsson PS, Ochani M et al (2011) Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334:98–101. https://doi.org/10.1126/science.1209985
doi: 10.1126/science.1209985
pubmed: 21921156
pmcid: 4548937
Scheid P, Bohadana A, Martinet Y (2000) Nicotine Patches for aphthous ulcers due to Behçet’s syndrome. N Engl J Med 343:1816–1817. https://doi.org/10.1056/NEJM200012143432418
doi: 10.1056/NEJM200012143432418
pubmed: 11185607
Scott DGI (2000) Systemic vasculitis: epidemiology, classification and environmental factors. Ann Rheum Dis 59:161–163. https://doi.org/10.1136/ard.59.3.161
doi: 10.1136/ard.59.3.161
pubmed: 10700420
pmcid: 1753099
Shooshtari P, Huang H, Cotsapas C (2017) Integrative genetic and epigenetic analysis uncovers regulatory mechanisms of autoimmune disease. Am J Hum Genet 101:75–86. https://doi.org/10.1016/j.ajhg.2017.06.001
doi: 10.1016/j.ajhg.2017.06.001
pubmed: 28686857
pmcid: 5501874
Sivadasan A, Muthusamy K, Patel B, et al. Clinical spectrum, therapeutic outcomes, and prognostic predictors in sjogren’s syndrome-associated neuropathy. Ann Indian Acad Neurol 20:278–283. doi: https://doi.org/10.4103/aian.AIAN_116_17
Spagnolo P, Cordier J-F, Cottin V (2016) Connective tissue diseases, multimorbidity and the ageing lung. Eur Respir J 47:1535–1558. https://doi.org/10.1183/13993003.00829-2015
doi: 10.1183/13993003.00829-2015
pubmed: 26917611
Stegemann A, Böhm M (2020) Targeting the α7 nicotinic acetylcholine receptor -a novel road towards the future treatment of skin diseases. Exp Dermatol. https://doi.org/10.1111/exd.14173
doi: 10.1111/exd.14173
pubmed: 32780438
Stegemann A, Sindrilaru A, Eckes B et al (2013) Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model. Arthritis Rheum 65:792–804. https://doi.org/10.1002/art.37809
doi: 10.1002/art.37809
pubmed: 23440693
Stegemann A, Flis D, Ziolkowski W et al (2020) The α7 nicotinic acetylcholine receptor: a promising target for the treatment of fibrotic skin disorders. J Invest Dermatol. https://doi.org/10.1016/j.jid.2020.04.006
doi: 10.1016/j.jid.2020.04.006
pubmed: 32335129
Stojanovich L (2009) Autonomic dysfunction in autoimmune rheumatic disease. Autoimmun Rev 8:569–572. https://doi.org/10.1016/j.autrev.2009.01.018
doi: 10.1016/j.autrev.2009.01.018
pubmed: 19393212
Stojanovich L, Milovanovich B, de Luka SR et al (2007) Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus 16:181–185. https://doi.org/10.1177/0961203306076223
doi: 10.1177/0961203306076223
pubmed: 17432103
Straub RH, Baerwald CG, Wahle M, Jänig W (2005) Autonomic dysfunction in rheumatic diseases. Rheum Dis Clin North Am 31:61–75. https://doi.org/10.1016/j.rdc.2004.09.002
doi: 10.1016/j.rdc.2004.09.002
pubmed: 15639056
Streifler JY, Molad Y (2014) Connective tissue disorders. pp 463–473
Tarn J, Legg S, Mitchell S et al (2019) The effects of noninvasive vagus nerve stimulation on fatigue and immune responses in patients with primary Sjögren’s syndrome. Neuromodulation Technol Neural Interface 22:580–585. https://doi.org/10.1111/ner.12879
doi: 10.1111/ner.12879
Tracey KJ (2002) The inflammatory reflex. Nature 420:853–859
doi: 10.1038/nature01321
Tracey KKJ (2007) Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117:289–296. https://doi.org/10.1172/JCI30555
doi: 10.1172/JCI30555
pubmed: 17273548
pmcid: 1783813
van Maanen MA, Lebre MC, van der Poll T et al (2009a) Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 60:114–122. https://doi.org/10.1002/art.24177
doi: 10.1002/art.24177
pubmed: 19116908
van Maanen MA, Vervoordeldonk MJ, Tak PP (2009b) The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol 5:229–232. https://doi.org/10.1038/nrrheum.2009.31
doi: 10.1038/nrrheum.2009.31
pubmed: 19337288
van Maanen MA, Stoof SP, LaRosa GJ et al (2010) Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor 7 subunit gene knockout mice. Ann Rheum Dis 69:1717–1723. https://doi.org/10.1136/ard.2009.118554
doi: 10.1136/ard.2009.118554
pubmed: 20511609
Wang HH, Yu M, Ochani M et al (2003) Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 421:384–388. https://doi.org/10.1038/nature01339
doi: 10.1038/nature01339
pubmed: 12508119
Watts RA, Scott DGI (2009) Recent developments in the classification and assessment of vasculitis. Best Pract Res Clin Rheumatol 23:429–443. https://doi.org/10.1016/j.berh.2008.12.004
doi: 10.1016/j.berh.2008.12.004
pubmed: 19508949
Watts RA, Lane SE, Bentham G, Scott DG (2000) Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 43:414–419. https://doi.org/10.1002/1529-0131(200002)43:2%3c414::AID-ANR23%3e3.0.CO;2-0
doi: 10.1002/1529-0131(200002)43:2<414::AID-ANR23>3.0.CO;2-0
pubmed: 10693883
Westman M, Saha S, Morshed M, Lampa J (2010) Lack of acetylcholine nicotine alpha 7 receptor suppresses development of collagen-induced arthritis and adaptive immunity. Clin Exp Immunol 162:62–67. https://doi.org/10.1111/j.1365-2249.2010.04204.x
doi: 10.1111/j.1365-2249.2010.04204.x
pubmed: 20659128
pmcid: 2990930
Wu S, Luo H, Xiao X et al (2014) Attenuation of collagen induced arthritis via suppression on Th17 response by activating cholinergic anti-inflammatory pathway with nicotine. Eur J Pharmacol 735:97–104. https://doi.org/10.1016/j.ejphar.2014.04.019
doi: 10.1016/j.ejphar.2014.04.019
pubmed: 24755145
Wu S, Zhou Y, Liu S et al (2018) Regulatory effect of nicotine on the differentiation of Th1, Th2 and Th17 lymphocyte subsets in patients with rheumatoid arthritis. Eur J Pharmacol 831:38–45. https://doi.org/10.1016/j.ejphar.2018.04.028
doi: 10.1016/j.ejphar.2018.04.028
pubmed: 29715455
Yanaba K (2016) Strategy for treatment of fibrosis in systemic sclerosis: present and future. J Dermatol 43:46–55. https://doi.org/10.1111/1346-8138.13026
doi: 10.1111/1346-8138.13026
pubmed: 26782006
Yin Q, Wu Y, Pan S et al (2020) Activation of cholinergic anti-inflammatory pathway in peripheral immune cells involved in therapeutic actions of α-mangostin on collagen-induced arthritis in rats. Drug Des Devel Ther 14:1983–1993. https://doi.org/10.2147/DDDT.S249865
doi: 10.2147/DDDT.S249865
pubmed: 32546965
pmcid: 7250306
Yoshikawa H, Kurokawa M, Ozaki N et al (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-?B phosphorylation and nuclear factor-?B transcriptional activity through nicotinic acetylcholine receptor ?7. Clin Exp Immunol 146:116–123. https://doi.org/10.1111/j.1365-2249.2006.03169.x
doi: 10.1111/j.1365-2249.2006.03169.x
pubmed: 16968406
pmcid: 1809735
Younger DS (2019) Overview of the vasculitides. Neurol Clin 37:171–200. https://doi.org/10.1016/j.ncl.2019.01.005
doi: 10.1016/j.ncl.2019.01.005
pubmed: 30952404
Zachs DP, Offutt SJ, Graham RS et al (2019) Noninvasive ultrasound stimulation of the spleen to treat inflammatory arthritis. Nat Commun 10:951. https://doi.org/10.1038/s41467-019-08721-0
doi: 10.1038/s41467-019-08721-0
pubmed: 30862842
pmcid: 6414603
Zhang P, Qin L, Zhang G (2010) The potential application of nicotinic acetylcholine receptor agonists for the treatment of rheumatoid arthritis. Inflamm Res 59:415–417. https://doi.org/10.1007/s00011-010-0160-1
doi: 10.1007/s00011-010-0160-1
pubmed: 20111886
Zhao J, Li Z (2018) The challenges of early diagnosis and therapeutic prediction in rheumatoid arthritis. Int J Rheum Dis 21:2059–2062. https://doi.org/10.1111/1756-185X.13459
doi: 10.1111/1756-185X.13459
pubmed: 30681275
Zila I, Mokra D, Kopincova J et al (2017) Vagal-immune interactions involved in cholinergic anti-inflammatory pathway. Physiol Res 66:S139–S145. https://doi.org/10.33549/physiolres.933671
doi: 10.33549/physiolres.933671
pubmed: 28937230